THORAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Thorazine, and what generic alternatives are available?
Thorazine is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in THORAZINE is chlorpromazine. There are twenty-four drug master file entries for this compound. Additional details are available on the chlorpromazine profile page.
Summary for THORAZINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Clinical Trials: | 4 |
Patent Applications: | 4,349 |
Formulation / Manufacturing: | see details |
DailyMed Link: | THORAZINE at DailyMed |
Recent Clinical Trials for THORAZINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Varun Monga, MD | Phase 1 |
Carlo Besta Neurological Institute | Phase 2 |
Regina Elena Cancer Institute | Phase 2 |